human colon tumour ht29 cells (ATCC)
99
Structured Review
ATCC
human colon tumour ht29 cells
Human Colon Tumour Ht29 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 2946 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+colon+tumour+ht29+cells/HT-29/pm30627877-39-0-8
Average 99 stars, based on 2946 article reviews
Human Colon Tumour Ht29 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 2946 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+colon+tumour+ht29+cells/HT-29/pm30627877-39-0-8
Average 99 stars, based on 2946 article reviews
human colon tumour ht29 cells - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Modification:Article Title: Inhibition of AKT signalling by benzoxazine derivative LTUR6 through the modulation of downstream kinases. Article Snippet: Many compounds structurally similar to chromones have been developed to enhance the sensitizing effect of cancer cells to chemotherapeutic agents.. Most of these compounds have been shown to promote this sensitization by targeting the repair pathways.. One such compound is LTUR6, which enhances the sensitization of doxorubicin to colon cancer cells HT29, by inhibiting the phosphorylation of the double stranded break (DSB) repair enzyme AKT. In Vitro:Article Title: Inhibition of AKT signalling by benzoxazine derivative LTUR6 through the modulation of downstream kinases. Article Snippet: Many compounds structurally similar to chromones have been developed to enhance the sensitizing effect of cancer cells to chemotherapeutic agents.. Most of these compounds have been shown to promote this sensitization by targeting the repair pathways.. One such compound is LTUR6, which enhances the sensitization of doxorubicin to colon cancer cells HT29, by inhibiting the phosphorylation of the double stranded break (DSB) repair enzyme AKT. |